Clinical benefit of baricitinib treatment for moderate-to-severe atopic dermatitis in combination with topical corticosteroids: a post hoc analysis of the BREEZE-AD7 and BREEZE-AD4 phase III trials
BRITISH JOURNAL OF DERMATOLOGY（2022）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined